DEep VEin Lesion OPtimisation (DEVELOP) Trial

Status Recruiting

Clinical Trial Summary

This is a prospective, single centre, randomised controlled, feasibility study recruiting patients with lower limb venous ulceration and Great Saphenous incompetence. Patients will be randomised to undergo either truncal ablation and compression therapy or truncal ablation, simultaneous iliac interrogation with intravascular ultrasound and stenting of significant (>50%) iliac vein lesions plus compression therapy. The primary endpoints will be ulcer healing and procedural safety. Secondary endpoints include time to healing, quality of life and clinical scores, ulcer recurrence rates and rates of post-thrombotic syndrome. Follow up will be over a five-year period. This feasibility study is designed to include 60 patients. Should it be practicable a total of 594 patients would be required to adequately power the study to definitively address ulcer-healing rates.

Clinical Trial Description

The single main research question for this trial is as follows: in adult patients with venous ulceration and great saphenous vein incompetence; does iliac vein assessment with IVUS and stenting of significant occlusive disease in addition to superficial great saphenous venous ablation and compression compared to superficial venous ablation and compression alone offer improved ulcer healing rates at three months following treatment? Primary Objective To determine whether superficial venous ablation plus early iliac vein interrogation plus endovascular stenting in the presence of significant occlusive disease results in improved venous ulcer healing compared to superficial venous ablation plus compression therapy alone. Secondary Objectives 1. To determine the relative performance of duplex ultrasound compared to IVUS for the prediction of NIVLs 3. To determine the rate of primary or recurrent ulceration up to five years following intervention 4. To assess patient quality of life in the short and medium term following each mode of intervention ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03640689
Study type	Interventional
Source	National University of Ireland, Galway, Ireland
Contact
Status	Recruiting
Phase	N/A
Start date	July 15, 2019
Completion date	September 1, 2024

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03903692` - A Comparative Evaluation of a MPS Dressing and a CMC Dressing on Subjects With Lower Extremity Venous Ulcers	N/A
Completed	`NCT03257254` - Effect of VarIthena on Wound Healing in Venous Leg Ulcers (VLU)
Recruiting	`NCT03666754` - Early Glue Saphenous Vein Ablation With Compression Versus Compression Alone in the Healing of the Venous Ulcer	N/A
Withdrawn	`NCT02912858` - Intermittent Pneumatic Compression of the Foot vs Geko Plus R-2 Neuromuscular Electrostimulation Device in Venous Leg Ulcer Patients	N/A
Completed	`NCT02482038` - Geko Venous Leg Ulcer Study	N/A
Completed	`NCT02652572` - Safety Study to Examine the Systemic Exposure of Granexin® Gel After Topical Application to Venous Leg Ulcers	Phase 1
Unknown status	`NCT01658618` - Safety Study Providing 12 Months Follow-up From First Exposure to HP802-247 in Subjects With Venous Leg Ulcer	N/A
Completed	`NCT05646121` - Suprasorb® A + Ag in the Treatment of Wounds at Risk of Infection and Infected Wounds
Completed	`NCT03077165` - Dose-response Relationship Study of S42909 on Leg Ulcer Healing	Phase 2
Completed	`NCT04461132` - The Effect of Manual Lymphatic Drainage	N/A
Completed	`NCT05974982` - Treatment Outcome of Autologous PRP Versus Conventional Therapy Among Patients With Chronic Venous Leg Ulcers	Phase 1
Completed	`NCT04011371` - Cyanoacrylate Closure for Treatment of Venous Leg Ulcers	N/A
Not yet recruiting	`NCT03543007` - Evaluating the Safety and Efficacy of GrafixPL™PRIME for the Treatment of Chronic Venous Leg Ulcers	N/A
Completed	`NCT03286140` - Early Venous Reflux Ablation Ulcer Trial	N/A
Recruiting	`NCT05588583` - A Clinical Investigation to Follow the Progress of Exuding Chronic Wounds Using Mepilex® Up as the Primary Dressing.	N/A
Not yet recruiting	`NCT04613687` - Efficacy and Safety of a New Compression System URGO BD001 in the Treatment of VLU (FREEDOM)	N/A
Recruiting	`NCT05549609` - A Study of XSTEM-VLU in Patients With Difficult-to-heal Venous Leg Ulcers	Phase 1/Phase 2
Recruiting	`NCT05409976` - The GORE® VIAFORT Vascular Stent IVC Study	N/A
Not yet recruiting	`NCT05089890` - Clinical Investigation of Sorbact® Dressings	N/A
Not yet recruiting	`NCT03670329` - Management of Infection Risk in Non-comparative Trial (MINT)	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

DEep VEin Lesion OPtimisation (DEVELOP) Trial — Develop

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms